E.g., 04/29/2024
E.g., 04/29/2024
Title Category Credit Event date Pricesort ascending
Incorporating the AUA/SUO Guideline on Advanced Prostate Cancer into Practice Webcast (2023)
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 Non-Physician Participation
 $0.00 Incorporating the AUA/SUO Guideline on Advanced Prostate Cancer into Practice (2023) is an exciting new educational initiative to update urologists on the most recent clinical guideline for the management of advanced prostate cancer. This course features a Moderator and three other subject matter experts engaging in an interactive, interview-style presentation and discussion.  
The Role of PARP Inhibitors in Advanced Prostate Cancer Webcast (2023)
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 Non-Physician Participation
 $0.00 Based on the documented need from the most recent AUA needs assessment in advanced prostate cancer, this symposium will address the role of PARP Inhibitor treatment, as well as evidence and outcomes of PARP Inhibitors as outlined in the newly amended Advanced Prostate Cancer: AUA/SUO Guideline. ACKNOWLEDGEMENTThis educational activity is supported by an independent educational grant from:Pfizer, Inc.
Advances in ADT Part II: A Guide for Urologists Webcast (2023)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
 $0.00 Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessment, the AUA has created Advances in ADT: Part II: A Guide for Urologists (2023), an educational offering to further update urologists on the latest advancements in androgen deprivation therapy (ADT) and prostate cancer treatment.
Contemporary Pharmacotherapy for OAB 2023: Monotherapy and Combined Pharmacotherapy to Optimize Treatment Webcast (2023)
    • 2.00 AMA PRA Category 1 Credit™
    • 2.00 Non-Physician Participation
 $0.00 Much has been written and debated about drug treatment of overactive bladder (OAB) over the past two decades. Nevertheless, the field continues to evolve. OAB pharmacotherapy remains an area of active investigation and innovation.

Pages